[ Price : $8.95]
FDA issues Alar Pharmaceuticals an untitled letter over promotional materials for its investigational ketamine drug, ALA-3000, bec...[ Price : $8.95]
FDAs approval of new drugs is increasingly being supported by fewer clinical studies.[ Price : $8.95]
Attorneys from Arnall Golden Gregory examine and offer advice on FDAs intensified scrutiny of drug advertising, advising companies...[ Price : $8.95]
A new report from Senate HELP chair Bill Cassidy (R-LA) targets FDA for allowing the abortion drug mifepristones Risk Evaluation a...[ Price : $8.95]
Rep. Lauren Boebert introduces legislation to remove some barriers to the development of botanical drugs.[ Price : $8.95]
Five stakeholders support an FDA proposal for an expedited IND pilot program and suggest ways to improve it.[ Price : $8.95]
Akin Gump attorneys highlight major issues in the PDUFA 8 commitment letter that is now open for public comment.[ Price : $8.95]
MasterControl issues its 2026 life sciences regulatory readiness playbook demonstrating the significant ways in which the FDA Qual...